Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, meth

Details Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, meth Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, meth

1996-10-18

1998-01-06

Robinson, Allen J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514176, 540113, 552510, 552548, 552552, 552558, 552614, 552617, 552618, 552624, 552626, A61K 3156, A61K 3158, C07J 100, C07J 5300

Patent

active

057054959

ABSTRACT:
The invention relates to new sulfamate derivatives of 1,3,5(10)-estratriene derivatives of the general formula I ##STR1## wherein the 3-sulfamate moiety is acylated, sulfonated or amidosulfonated. Furthermore, methods for the production of the compound and pharmaceutical preparations containing this compound are described. The compounds according to the invention have an estrogenic effect.

REFERENCES:
patent: 5556847 (1996-09-01), Johnson et al.
patent: 5604215 (1997-02-01), Reed et al.
patent: 5616574 (1997-04-01), Reed et al.

Affiliated with

Also associated with

Rating

Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, meth does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, meth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, meth will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2329299